An observational study in Lung Transplantation, Rejection and Death, sponsored by Hannover Medical School. Completed at 1 site in Germany. Open to participants aged 18 Years to 70 Years. Per ClinicalTrials.gov, last updated 2008-08-29.
Sponsored by Hannover Medical School · Observational
Prospective cohort, mono-center study included electronic data of home spirometry (HS, lung function) of lung transplant recipients
Study period between 1/2/2000 and 31/12/2003 Follow-up until 31/12/2007
Patient will be stratified according to adherence to HS during the first 2 postoperative years Good adherent patient: patient performed ≥ 80% of predicted HS within 24 months Moderate adherent patient: patient performed ≥ 50% of predicted HS within 24 months Non-adherent patient: patient performed \< 50% of predicted HS within 24 months.
Primary outcome measure graft loss at end of follow-up
Secondary outcome measure number of acute rejections during follow-up number of hospitalisation during follow-up Incidence of bronchiolitis obliterans syndrome during follow-up
360 studies on the registry are indexed under Bronchiolitis; 43 are open to participants now.
This study's enrollment of 152 is below the median of 196 across 92 observational studies indexed under Bronchiolitis.
Browse Bronchiolitis studies →Hannover Medical School is the lead sponsor of 198 studies on the registry; 24 are open to participants now.
Counted across the registry records on this site, refreshed daily.
lung transplant recipients surviving to outpatient follow-up >6 months in Hannover Medical School
Exclusion Criteria:
Good adherent patient: patient performed ≥ 80% of predicted HS within 24 months
Moderate adherent patient: patient performed ≥ 50% of predicted HS within 24 months
Non-adherent patient: patient performed \< 50% of predicted HS within 24 months.
Graft loss
Time frame: 3 year
BOS
Time frame: 3 year
Number of acute rejections
Time frame: 3 year
Number of hospitalizations
Time frame: 3 year
This study is completed, as verified in Aug 2008. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Hannover Medical School